Teleflex Incorporated (NYSE:TFX - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $118.70 and last traded at $120.14, with a volume of 25880 shares trading hands. The stock had previously closed at $119.66.
Analysts Set New Price Targets
Several brokerages have issued reports on TFX. Raymond James lowered Teleflex from an "outperform" rating to a "market perform" rating in a research report on Friday, February 28th. Mizuho set a $155.00 price target on Teleflex in a report on Wednesday, April 16th. Needham & Company LLC reiterated a "hold" rating on shares of Teleflex in a report on Wednesday, March 12th. Truist Financial lowered their price target on Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a report on Monday, May 5th. Finally, Royal Bank of Canada lowered their price target on Teleflex from $150.00 to $145.00 and set a "sector perform" rating for the company in a report on Friday, May 2nd. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $164.63.
Check Out Our Latest Analysis on Teleflex
Teleflex Stock Up 1.1%
The business's 50 day moving average is $128.83 and its 200 day moving average is $156.25. The company has a market cap of $5.43 billion, a P/E ratio of 24.42, a P/E/G ratio of 1.73 and a beta of 1.17. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.
Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.88 by $0.03. The business had revenue of $700.67 million for the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business's quarterly revenue was down 5.0% on a year-over-year basis. During the same period in the prior year, the firm posted $3.21 earnings per share. As a group, equities analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.
Teleflex Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Tuesday, May 20th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.11%. The ex-dividend date is Tuesday, May 20th. Teleflex's payout ratio is 42.90%.
Hedge Funds Weigh In On Teleflex
Hedge funds have recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB increased its position in shares of Teleflex by 103.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock valued at $27,000 after acquiring an additional 100 shares during the period. Banque Cantonale Vaudoise acquired a new stake in Teleflex during the 1st quarter worth about $27,000. Costello Asset Management INC acquired a new stake in Teleflex during the 1st quarter worth about $28,000. Headlands Technologies LLC acquired a new stake in Teleflex during the 4th quarter worth about $29,000. Finally, Brooklyn Investment Group grew its position in Teleflex by 258.6% during the 1st quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company's stock worth $29,000 after purchasing an additional 150 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.
About Teleflex
(
Get Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Further Reading
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
